1 MG | x |
Save $ 24.00 |
$ 454.00
|
2.5 MG | x |
Save $ 38.00 |
$ 732.00
|
5 MG | x |
Save $ 79.00 |
$ 1,501.00
|
Chemical Properties of 'Doxorubicinol Hydrochloride' |
|
CAT No. : |
CS-O-07808 |
CAS Registry No. : | 63950-05-0 |
Category : | Metabolites |
Molecular Weight: | 582.00 |
Molecular Formula : | C₂₇H₃₂ClNO₁₁ |
OTHER INFORMATION of 'Doxorubicinol Hydrochloride' |
|
Purity : | Not less than 90% |
Therapeutic : | Anti-Cancer / Oncology |
Purity : | Not less than 90% |
Therapeutic : | Anti-Cancer / Oncology |
IUPAC Name : | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-[(1S)-1,2-dihydroxyethyl]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride |
Applicationnotes : | A metabolite of Doxorubicin as neoplasm inhibitor |
Synonym : | Not available |
References : | "Smith; T,H,; et al,: J, Med, Chem,; 22; 40 (1979);" |
Smileys : | CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)N)O.Cl |
Appearance : | Orange red solid |
Related CAS : | 141434-67-5 (Parent) |
UNII : | 9LVW1H75S7 |
Other Synonyms : | Doxorubicinol hydrochloride |
Removed Synonyms : | AC1L48AO |
Exact Mass : | 581.1663885 |
InChI : | InChI=1S/C27H31NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15-17,22,29-31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,16-,17-,22+,27-;/m0./s1 |
InchIKey : | ORLHIGGRLIJIIM-PNOIAXSSSA-N |
Canonical SMILES : | CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)N)O.Cl |
Isomeric SMILES : | C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)([C@H](CO)O)O)N)O.Cl |
Custom Duty : | Applicable |
Port of Loading : | Canada |
Expected Dispatch : | 15-Aug-2022 |
Taxes : | Not Applicable |
Refund Policy : | 30-days money back |
Custom Duty : | Applicable |
Port of Loading : | Canada |
Expected Dispatch : | 15-Aug-2022 |
Taxes : | Not Applicable |
Refund Policy : | 30-days money back |
Doxorubicin, sold under the brand name Adriamycin among others, is a chemotherapy medication used to treat cancer. This includes breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia. It is often used together with other chemotherapy agents. Doxorubicin is given by injection into a vein.
Common side effects include hair loss, bone marrow suppression, vomiting, rash, and inflammation of the mouth. Other serious side effects may include allergic reactions such as anaphylaxis, heart damage, tissue damage at the site of injection, radiation recall, and treatment-related leukemia. People often experience red discoloration of the urine for a few days. Doxorubicin is in the anthracycline and antitumor antibiotic family of medications. It works in part by interfering with the function of DNA.
Doxorubicin was approved for medical use in the United States in 1974. It is on the World Health Organization's List of Essential Medicines. Versions that are pegylated and in liposomes are also available; however, they are more expensive. Doxorubicin was originally made from the bacterium Streptomyces peucetius.
Looking for a discounted price or need more info for 'Doxorubicinol Hydrochloride (CS-O-07808)' ?
If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.